T. Rowe Price Associates, Inc. 13D and 13G filings for Therapeutics Acquisition Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 12:24 pm Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | T. Rowe Price Associates, Inc. | 921,822 5.200% | 921,822 (New Position) | Filing |